Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

3.27 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 67.95546.9366.88694.91777.24877.999130.101157.54111.067108.764122.162135.80268.81241.40743.777-6.552
Short Term Investments 192.517205.582176.636120.51767.63362.4147.50442.65478.84480.32672.07564.16200013.104
Cash and Short Term Investments 260.472252.512243.522215.434144.881140.409177.605200.194189.911189.09194.237199.96468.81241.40743.7776.552
Net Receivables 0.1060.1890.225000000000.1090.1090.1090.1090
Inventory 0.121000000000000000
Other Current Assets 6.3373.132.8683.1644.6573.6232.7242.3661.1423.0084.4244.841.6510.5870.5430
Total Current Assets 266.915255.831246.615218.598149.538144.032180.329202.56191.053192.098198.661204.91370.57242.10344.4296.552
Non-Current Assets:
Property, Plant & Equipment, Net 0.430.470.5030.1250.1650.2180.270.2750.280.2520.0360.0130.006000
Goodwill 0000000000000000
Intangible Assets 0.184000000000000000
Goodwill and Intangible Assets 0.184000000000000000
Long Term Investments 20.90844.10862.55367.2727.31143.41915.837020.00127.65831.61929.910000
Tax Assets -0.184000000000000000
Other Non-Current Assets 0.660.5580.4540.3780.3910.1950.1510.4290.3440.0790.0140.0132.3650.270-6.552
Total Non-Current Assets 21.99845.13663.5167.77327.86743.83216.2580.70420.62527.98931.66929.9362.3710.270-6.552
Total Assets 288.913300.967310.125286.371177.405187.864196.587203.264211.678220.087230.33234.84972.94342.37344.4290
Liabilities & Equity:
Current Liabilities:
Account Payables 4.2113.0791.3791.3622.0260.7621.642.0841.711.2191.0880.3822.9070.9180.5310
Short Term Debt 0.1250.1210.8660.0020.0290.0670.1050.1330.1420.139000000
Tax Payables 0000000000000000
Deferred Revenue 0000000000000000
Other Current Liabilities 11.0315.27210.7264.7346.4767.956.0674.3963.2822.5784.0591.1071.61130.2645.8360
Total Current Liabilities 15.3678.47212.9716.0988.5318.7797.8126.6135.1343.9365.1471.4894.51831.1826.3670
Non-Current Liabilities:
Long Term Debt 28.08927.85127.621000000.0250.062000000
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities 1.512.612.56000000000174.50456.65356.6530
Total Non-Current Liabilities 29.59930.46130.181000000.0250.06200174.50456.65356.6530
Total Liabilities 44.96638.93343.1526.0988.5318.7797.8126.6135.1593.9985.1471.489179.02287.83563.020
Equity:
Preferred Stock 00000000000000017.4
Common Stock 0.0060.0060.0060.0060.0040.0040.0040.0040.0040.0040.0040.0040000
Retained Earnings -258.208-237.671-222.798-206.301-193.344-181.734-170.427-157.561-146.851-136.7-127.571-119.222-115.32-53.962-26.9650
Accumulated Other Comprehensive Income/Loss -0.164-0.1440.312-0.509-0.646-0.524-0.751-0.965-0.965-0.814-0.231-0.028000-11.42
Other Total Stockholders Equity 502.313499.843489.453487.077362.86361.339359.949355.173354.331353.599352.981352.6069.2418.58.3740
Total Shareholders Equity 243.947262.034266.973280.273168.874179.085188.775196.651206.519216.089225.183233.36-106.079-45.462-18.5915.98
Total Equity 243.947262.034266.973280.273168.874179.085188.775196.651206.519216.089000005.98
Total Liabilities & Shareholders Equity 288.913300.967310.125286.371177.405187.864196.587203.264211.678220.087230.33234.84972.94342.37344.4295.98